Original Source(s)
FDA Expands Afrezza to Pediatric Diabetes
-
by Kathryn Wighton
May 29, 2026
Related Content
Sex Disparities May Persist in CF Despite Modulators
Review findings suggested female patients with cystic fibrosis may continue to experience worse pulmonary outcomes despite highly effective modulator therapy
May 22, 2026
-
6 min
Can Lower Music Levels Preserve Workout Intensity?
Despite preserved exertion perceptions, researchers report limited hearing protection use in group fitness classes.
May 22, 2026
-
4 min